← Back to All Filings

Resmed Officer Files Intent to Sell $743K in RMD Stock via 10b5-1 Plan

Low SignificanceNovember 3, 2025 at 10:31:59 AM EST

RESMED INC

$RMD144CIK: 0000943819

Subscribe to track RMD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Resmed Officer Files Intent to Sell $743K in RMD Stock

Company: RESMED INC (RMD) Form: 144 | Filed: 2025-11-03 Significance: Low

Insider: Sandercock Brett Title: Not Specified | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 3,000 • Price: ~$247.54 • Value: $742,620 • Owned After: Not Disclosed

Key Insight: This is a routine, low-value proposed sale conducted under a pre-scheduled 10b5-1 trading plan, indicating it is not based on new non-public information.

Market Context: The transaction represents a negligible 0.002% of the company's $36.04B market cap. The insider has a history of similar small, periodic sales.

Comprehensive Analysis

SEC Filing Analysis: RESMED INC (RMD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at Resmed has filed a notice of intent to sell 3,000 shares valued at approximately $743k under a pre-arranged 10b5-1 trading plan.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to have any impact on the stock price.

Company Information

FieldValue
CompanyRESMED INC
Ticker SymbolRMD
CIK0000943819
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameSandercock Brett
CIK0001346064
Title/PositionNot Specified
RelationshipOfficer

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025-11-03 (Approximate)
Transaction CodeNot Applicable
Security TypeCommon
Shares Involved3,000
Price Per Share~$247.54
Total Value$742,620
Shares Owned AfterNot Disclosed
Ownership TypeNot Specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$742,620
% of Market Cap0.002%
Shares Transacted3,000
% of Shares Outstanding0.002%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $36.04 billion, this $743k transaction is financially insignificant.
  • Transaction Significance: The sale represents a negligible fraction of both the company's market value and its total shares outstanding, indicating a routine transaction with no material impact.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is extremely small and was executed under a 10b5-1 plan adopted in February 2025. Such pre-planned sales are common for executive compensation and liquidity and do not signal a change in the insider's outlook on the company.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small to affect trading volume.
  • Sentiment Indicator: Neutral. The filing is a routine notice and provides no new information to influence market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The sale is proposed under a 10b5-1 trading plan adopted on February 19, 2025. The filing also discloses two similar sales of 3,000 shares each in the prior three months, reinforcing the planned, periodic nature of these dispositions.
Topics:#SECFiling#InsiderTrading#RMD#Resmed#Form144#InsiderSell#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.